Special Considerations in the Management of Women With HIV, Including Management of Conception and Pregnancy
Summary
- IV zidovudine near delivery is recommended for pregnant women with HIV-1 RNA > 1000 copies/mL or unknown HIV-1 RNA levels unless there is evidence of resistance or toxicity (Management Guidelines)[DHHS Perinatal]
- Neonatal ART prophylaxis is also recommended:[DHHS Perinatal]
- Full-term infants whose mother received a suppressive ART regimen during pregnancy: zidovudine for 4 weeks
Mode of Delivery
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content